Crinetics Pharmaceuticals Operating Expenses Growth & History (CRNX)
Crinetics Pharmaceuticals's operating expenses was $524.5M for fiscal 2025.
View full Crinetics Pharmaceuticals company overviewCrinetics Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $524.5M | $184.6M | +54.30% |
| 2024 | 2024-12-31 | $339.9M | $113.3M | +49.98% |
| 2023 | 2023-12-31 | $226.6M | $54.0M | +31.28% |
| 2022 | 2022-12-31 | $172.6M | $63.8M | +58.69% |
| 2021 | 2021-12-31 | $108.8M | $33.8M | +44.99% |
| 2020 | 2020-12-31 | $75.0M | $20.0M | +36.35% |
| 2019 | 2019-12-31 | $55.0M | $23.9M | +76.71% |
| 2018 | 2018-12-31 | $31.1M | $20.0M | +178.71% |
| 2017 | 2017-12-31 | $11.2M | $4.5M | +68.43% |
| 2016 | 2016-12-31 | $6.6M | — | — |
Crinetics Pharmaceuticals quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $157.6M | $27.4M | +21.08% |
| Q1 2026 | 2026-03-31 | $151.1M | $39.3M | +35.20% |
| Q4 2025 | 2025-12-31 | $139.8M | $45.1M | +47.58% |
| Q3 2025 | 2025-09-30 | $142.7M | $54.9M | +62.57% |
| Q2 2025 | 2025-06-30 | $130.1M | $47.0M | +56.46% |
| Q1 2025 | 2025-03-31 | $111.8M | $37.6M | +50.69% |
| Q4 2024 | 2024-12-31 | $94.7M | $32.1M | +51.21% |
| Q3 2024 | 2024-09-30 | $87.8M | $28.5M | +48.00% |
| Q2 2024 | 2024-06-30 | $83.2M | $29.2M | +54.09% |
| Q1 2024 | 2024-03-31 | $74.2M | $23.5M | +46.41% |
| Q4 2023 | 2023-12-31 | $62.7M | $14.4M | +29.82% |
| Q3 2023 | 2023-09-30 | $59.3M | $15.4M | +35.10% |
| Q2 2023 | 2023-06-30 | $54.0M | $10.5M | +24.14% |
| Q1 2023 | 2023-03-31 | $50.7M | $13.7M | +37.07% |
| Q4 2022 | 2022-12-31 | $48.3M | $16.3M | +50.99% |
| Q3 2022 | 2022-09-30 | $43.9M | $16.1M | +57.92% |
| Q2 2022 | 2022-06-30 | $43.5M | $17.4M | +66.68% |
| Q1 2022 | 2022-03-31 | $37.0M | $14.0M | +61.26% |
| Q4 2021 | 2021-12-31 | $32.0M | $10.2M | +46.69% |
| Q3 2021 | 2021-09-30 | $27.8M | $9.4M | +50.71% |
| Q2 2021 | 2021-06-30 | $26.1M | $9.2M | +54.11% |
| Q1 2021 | 2021-03-31 | $22.9M | $5.1M | +28.37% |
| Q4 2020 | 2020-12-31 | $21.8M | $6.3M | +40.27% |
| Q3 2020 | 2020-09-30 | $18.5M | $2.7M | +17.27% |
| Q2 2020 | 2020-06-30 | $16.9M | $3.6M | +26.86% |
| Q1 2020 | 2020-03-31 | $17.9M | $7.4M | +71.48% |
| Q4 2019 | 2019-12-31 | $15.5M | $5.3M | +52.12% |
| Q3 2019 | 2019-09-30 | $15.7M | $7.1M | +82.57% |
| Q2 2019 | 2019-06-30 | $13.3M | $7.0M | +110.49% |
| Q1 2019 | 2019-03-31 | $10.4M | $4.4M | +74.45% |
| Q4 2018 | 2018-12-31 | $10.2M | $7.2M | +237.14% |
| Q3 2018 | 2018-09-30 | $8.6M | $5.6M | +185.93% |
| Q2 2018 | 2018-06-30 | $6.3M | $3.9M | +156.16% |
| Q1 2018 | 2018-03-31 | $6.0M | $3.3M | +124.87% |
| Q4 2017 | 2017-12-31 | $3.0M | — | — |
| Q3 2017 | 2017-09-30 | $3.0M | — | — |
| Q2 2017 | 2017-06-30 | $2.5M | — | — |
| Q1 2017 | 2017-03-31 | $2.7M | — | — |
Crinetics Pharmaceuticals operating expenses trends
Over the last five fiscal years, Crinetics Pharmaceuticals's operating expenses increased from $75.0M to $524.5M, a change of $449.4M. The latest reported quarter, Q2 2026, shows $157.6M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crinetics Pharmaceuticals source filings ↗